Cell-based Antiviral Drug Discovery Platform

About Lucerna

Lucerna Technologies is a private, early-stage biotech company specializing in RNA-targeted research tools and drug discovery platforms. Its core intellectual property is the Spinach™ technology, an RNA aptamer system that fluoresces upon binding small-molecule dyes, allowing researchers to image and track RNA in real-time within living cells. The company has successfully commercialized research reagents, secured SBIR grant funding, and completed custom R&D projects for major pharmaceutical companies. Lucerna's strategic focus is on providing enabling tools to accelerate the identification and development of novel RNA-targeted therapeutics, particularly in splicing modulation and antiviral drug discovery.

Therapeutic Areas

Other Viral Infections Drugs